We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Texas Center for Proton Therapy Selects RayStation for Treatment Planning
Product News

Texas Center for Proton Therapy Selects RayStation for Treatment Planning

Texas Center for Proton Therapy Selects RayStation for Treatment Planning
Product News

Texas Center for Proton Therapy Selects RayStation for Treatment Planning


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Texas Center for Proton Therapy Selects RayStation for Treatment Planning"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Texas Center for Proton Therapy is a collaboration of Texas Oncology and The US Oncology Network, supported by McKesson Specialty Health and Baylor Health Enterprises, an affiliate of Baylor Health Care System.

The 63,000-square-foot facility in the Dallas/Fort Worth area will have capacity to treat more than 100 patients per day in three treatment rooms. It will be the first stand-alone LEED-Certified proton therapy center in the U.S. (Leadership in Energy and Environmental Design).

“It is our goal to provide advanced technologies such as robust optimization, PBS IMPT and full adaptive therapy, right from the start of clinical operations. We believe that RaySearch has a proven track record that can help us deliver on the promise of developing treatment plans with the best technology available today in proton therapy,” says Dr. Andrew Lee, Medical Director of the center.

“We will also utilize the wide area network available at the local Texas Oncology facilities so that we can share information and develop the best plans available for the patients. We can compare conventional photon plans with proton plans and choose the right course of action,” he concludes.

Dr. Lee joins Texas Center for Proton Therapy following almost 14 years at The University of Texas MD Anderson Cancer Center, where he pioneered many firsts in the field of proton therapy, including treating the first proton patient. He also served as the first and founding director of the Program for Advanced Technology, and as the Medical Director of the MD Anderson Proton Therapy Center.

“We are looking forward to working with Dr. Lee and Texas Center for Proton Therapy . They have developed a cutting edge center and we are proud to be a part of it”, says Marc Mlyn, President of RaySearch Americas. “RaySearch has also been added as one of the preferred providers of radiation therapy planning for The US Oncology Network, which is comprised of more than100 treatment facilities across the US. We are looking forward to a long and mutually beneficial relationship well into the future.”

“It is exciting to see such a high-end proton center come to life and to have RayStation® so well positioned to provide the advanced technology it requires. Texas Center for Proton Therapy is now the 17thproton center to choose RayStation® for its treatment planning and this is only the beginning as we are constantly striving to stay at the forefront of particle therapy. We are looking forward to the day Texas Center for Proton Therapy will treat their first patient”, says Johan Löf, CEO of RaySearch Laboratories.

The current version of RayStation® supports all relevant proton treatment techniques such as Uniform Scanning, Double Scattering and PBS / IMPT. It also features unique functionalities like Multi-Criteria Optimization (MCO) for PBS optimization.

MCO planning makes it possible to plan in a more interactive and exploratory way where fundamental trade-offs can be made in real time by the dosimetrist and the physician. It can help simplify the planning process while improving the quality of the plans.

Advertisement